Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Step-wise addition versus complete basal-bolus insulin therapy in type 2 diabetes
2010-018974-19Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Jul 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin aspart and insulin detemir in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Novo Nordisk. Primary endpoint: Change in HbA1c from baseline to week 32/end of trial. Started Jul 2010; status: completed.
02
Drugs
insulin aspartinsulin detemir
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2010-018974-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018974-19.